Integrated Biosciences, Inc.
United States
- San Carlos, California
- 04/10/2024
- Seed
- $17,000,000
We combine synthetic biology and machine learning to control cellular stress responses for next-generation therapeutics.
- Industry Biotechnology Research
- Website https://www.integratedbiosciences.com/
- LinkedIn https://www.linkedin.com/company/integrated-biosciences-inc/
Related People
Felix WongCo Founder
United States -
San Carlos, California
I am co-founder of Integrated Biosciences, an early-stage drug discovery company for age-related disease. Featured on the Forbes 30 Under 30 in Healthcare, I am also a research scientist at the Broad Institute of MIT and Harvard, supported by the NIH's K25 Mentored Quantitative Research Career Development Award.
As a physicist and mathematician by training, I am interested in applications of machine learning to biology, biophysics, cellular physiology, and drug discovery. My research has led to a better understanding of how drugs including antibiotics work, how the next generations of drugs can be discovered, how cells are built, and how infectious diseases spread.
AfterQuery | $30,000,000 | (Apr 10, 2026)
Plume (YC S24) | $3,900,000 | (Apr 10, 2026)
Rork | $15,000,000 | (Apr 10, 2026)
Haast | $12,000,000 | (Apr 10, 2026)
CareGlance Srl | $4,092,182 | (Apr 10, 2026)
Elorian AI | $55,000,000 | (Apr 10, 2026)
TeiaCare & Ancelia: AI for Care Homes | $8,184,645 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
Felix(1) | $1,700,000 | (Apr 10, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
Golden Analytics | $7,000,000 | (Apr 9, 2026)